We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Global Minimally Invasive Surgical (MIS) Instruments Market Driven by Growing Preference for MIS Procedures

By HospiMedica International staff writers
Posted on 17 Jul 2023

Minimally invasive surgical (MIS) procedures are designed to cause less trauma compared to traditional open surgeries, resulting in lower blood loss, minimal scarring, and reduced infection risks. More...

The demand for MIS procedures is on the rise due to their less traumatic nature and the faster recovery process they offer. Patients are able to return to their daily activities quicker following MIS procedures. Additionally, MIS procedures are significantly more cost-effective compared to in-patient and traditional open surgeries. As a result, the global MIS instruments market is projected to grow at a CAGR of 10.3% from 2023 to 2030, reaching USD 63 billion in 2030.

These are the latest findings of Grand View Research (San Francisco, CA, USA), a market research and consulting company.

Based on device, the handheld instruments segment accounted for the largest revenue share of the MIS instruments market in 2022. However, the electrosurgical devices segment is predicted to experience the fastest growth rate during the forecast period from 2023 to 2030. On the basis of application, the orthopedic segment held the largest revenue share of the MIS instruments market in 2022. MIS procedures within orthopedics provide surgical options that cause minimal tissue disruption. Furthermore, the ongoing adoption of MIS techniques for spine-related procedures has led to an increase in procedural volumes for orthopedic MIS.

Based on end use, the hospital segment held the largest revenue share of the MIS instruments market in 2022. However, the ambulatory surgical center segment is expected to experience the fastest growth in the coming years. Geographically, North America held the majority share of the global MIS instruments market in 2022, primarily due to the supportive reimbursement framework for innovative MIS devices and procedures in the region.

Related Links:
Grand View Research


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Warming Cabinet
EC1850BL
New
Enteral Feeding Pump
Instilar 1420
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.